SCHEMBL30199709

SCHEMBL30199709

COc1ccc([N+](=O)[O-])c(Br)c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.53
MAPK1 P28482 4/20 0.53
MAPT P10636 5/20 0.50
MEN1 O00255 5/20 0.50
KMT2A Q03164 5/20 0.50
RAB9A P51151 3/20 0.50
NPC1 O15118 2/20 0.50
SMN1; SMN2 Q16637 2/20 0.49
TDP1 Q9NUW8 1/20 0.49
L3MBTL1 Q9Y468 1/20 0.49
HTT P42858 1/20 0.49
PKM P14618 2/20 0.48
AKR1C3 P42330 3/20 0.48
AKR1C2 P52895 3/20 0.48
KDM4E B2RXH2 1/20 0.47
G6PD P11413 1/20 0.47
NPSR1 Q6W5P4 1/20 0.47
RXFP1 Q9HBX9 1/20 0.47
APOBEC3G Q9HC16 1/20 0.47
AKR1B10 O60218 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL228082 1.00 ALDH1A1 (0.53) ALDH1A1MAPK1MAPTMEN1KMT2A
SCHEMBL15541404 0.89 PIN1 (0.52) ALDH1A1MAPK1MAPTMEN1KMT2A
SCHEMBL6320 0.87 ALDH1A1 (0.55) ALDH1A1MAPK1MAPTMEN1KMT2A
SCHEMBL30585356 0.87 ALDH1A1 (0.55) ALDH1A1MAPK1MAPTMEN1KMT2A
SCHEMBL9200645 0.86 ALDH1A1 (0.50) ALDH1A1MAPK1MAPTMEN1KMT2A
SCHEMBL1662886 0.84 ALDH1A1 (0.65) ALDH1A1MAPK1MAPTMEN1KMT2A
SCHEMBL2986961 0.83 MAPT (0.48) ALDH1A1MAPK1MAPTMEN1KMT2A
SCHEMBL1981547 0.83 ALDH1A1 (0.42) ALDH1A1MAPK1MAPTMEN1KMT2A
SCHEMBL2987569 0.83 TLR4 (0.53) MAPK1MAPTMEN1KMT2ARAB9A
SCHEMBL30639026 0.83 MAPT (0.67) ALDH1A1MAPK1MAPTMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4121029-A1 BENZENESULFONAMIDE DERIVATIVES AS TRAP1 MODULATORS AND USES THEREOF Amathus Therapeutics, Inc. (US) 2023-01-25 EP disclosed